Faculty Information - SHIMIZU Tomokazu

Books

Published papers

Academic conference presentation

Social activities

Research grants & projects

Education

Rsearch funding number

（Last updated : 2024-04-12 11:53:38）

SHIMIZU Tomokazu
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine

Position Associate Professor

■ Books

1.	Chapter contribution	Current situation of ABO-incompatible kidney transplantation in Japan., ABO-incompatible Kidney Transplantation 2016
2.	Chapter contribution	Deoxyspergualin(gusperimus hydrocloride)「腎と透析　腎疾患治療薬マニュアル　2013-2014」 2013/04
3.	Chapter contribution	Immunoinsufficiency「腎と透析　腎疾患治療薬マニュアル　2013-2014」 2013/04
4.	Chapter contribution	Urologic infection「腎と透析　腎疾患治療薬マニュアル　2013-2014」 2013/04

■ Published papers

1.	Original article	Clinical course of candidate renal transplant recipients diagnosed with prostate cancer during pre-transplant screening test. 2024/01
2.	Original article	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. 2023/11
3.	Original article	A case of kidney transplantation for complete C4 deficiency with recurrent IgM-monoclonal gammopathy of renal significance (MGRS) associated nephropathy. 2023/09
4.	Original article	Comparison of three prognostic and predictive scores in 10 patients with COVID-19 pneumonia caused by nosocomial infection. 2023/07
5.	Original article	Case report: suspected hyperacute rejection during living kidney transplantation. 2023/05/01
6.	Original article	Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan academic consortium of kidney transplantation study-II. 2023/05
7.	Case report	Allogeneic kidney transplantation after COVID-19: A case report. 2022/07
8.	Case report	Case report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. 2022/07
9.	Case report	Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report. 2022/07
10.	Original article	Japanese single-center experience of kidney transplant: Experience in a Japanese private hospital. 2022/03
11.	Original article	Safe Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg. 2022/03
12.	Case report	Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report. 2022/01
13.	Case report	A case of novel coronavirus disease after combination therapy with nivolumab and ipilimumab for metastatic renal cell carcinoma. 2021/12/30
14.	Case report	Fluorescence in situ hybridization for the origin of de novo renal cell carcinoma in a kidney allograft: A case report. 2021/10
15.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation. 2021/06
16.	Review article	Renal allograft urolithiasis after renal transplantaion. 2020/12/10
17.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7-years of follow-up after renal transplantation. 2020/12
18.	Case report	Total nephroureterocystectomy and urethrectomy due to urothelial carcinoma associated with the BK polyomavirus infection after kidney transplantation: a case report with literature review. 2020/11
19.	Original article	Clinicopathologic analyses of chronic vascular rejection after kidney transplantation. 2020/07
20.	Original article	Post-donation satisfaction in kidney transplantation: a survey of living donors in Japan 2019/10/26
21.	Original article	Predictors of return to work after kidney transplantation: a 12-month cohort of the Japan Academic Consortium of Kidney Transplantation study 2019/10/03
22.	Original article	Monoclonal immunoglobulin G deposits on tubular basement membrane in renal allograft: is this significant for chronic allograft injury? 2019/04
23.	Original article	Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible:A randomized trial. 2018/12
24.	Original article	Follow-up Survey of Donor Candidates for Living Related Kidney Transplantation With Prostate Cancer. 2018/10
25.	Original article	Evaluation of microvascular inflammation in ABO-incompatible kidney transplantation. 2017/06
26.	Original article	Relationship between de novo donor-specific anti-HLA-DQ antibody and chronic antibody-mediated rejection in kidney transplant recipients. 2017/04
27.	Original article	Diabetes mellitus after kidney transplantation in Japanese patients:The Japan Academic Consortium of Kidney Transplantation study. 2017/03
28.	Original article	Assessment of 4 cases of kidney transplantation from hepatitis C virus antibody-positive and RNA-negative donors to antibody-negative recipients. 2016/09
29.	Original article	Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation. 2016/07
30.	Original article	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2016/07
31.	Case report	Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. 2016/07
32.	Case report	Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients 2016/04/01
33.	Original article	Efficacy and feasibility of low-dose rate brachytherapy for prostate cancer in renal transplant recipients. 2016/04/01
34.	Original article	Post-transplant lymphoproliferative disorder in kidney transplant recipients: A single-center experience in Japan. 2016/04
35.	Original article	Robot-assisted radical prostatectomy for localized prostate cancer in asian renal transplant recipients. 2016/04
36.	Original article	ABO-Incompatible living kidney transplants: Evolution of outcomes and immunosuppressive management. 2016/03
37.	Original article	Reliability of tacrolimus determination using Electro-Chemiluminesence Immunoas-say(ECLIA). 2016/03
38.	Original article	Effects of low-dose rituximab therapy in patients with primary cytomegalovirus infection. 2015/12
39.	Original article	Evaluation of the variability among two reference Flow Cytometry Crossmatch. 2015/10
40.	Case report	A Case of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation Associated With Variant Conversion in the Columbia Classification 2015/07
41.	Original article	Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015/07
42.	Original article	Clinical and pathological analyses of chronic vascular rejection after kidney transplantation. 2015/07
43.	Original article	The impact of C4d-negative acute antibody-mediated rejection on short-term prognosis among kidney transplant recipients. 2015/07
44.	Original article	Evaluation of assay methods for tacrolimus concentration on renal transplantation-CLIA, EMIT, and ECLIA- 2015/03
45.	Original article	Retroperitoneoscopic donor nephrectomy with multiple renal arteries does not affect graft survival and ureteral complications. 2014/12
46.	Original article	Clinical and pathological analyses of transplant glomerulopathy cases. 2014/06
47.	Original article	Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment. 2014/04
48.	Original article	Impact of right-sided nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy at single center 2013/10
49.	Original article	Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome 2013/09
50.	Original article	Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation: Prospective Trial in Once-Daily Versus Twice-Daily Tacrolimus 2013/07
51.	Original article	A case of focal segmental glomerulosclerosis diagnosed as the original underlying disease after cadaveric renal transplantation 2012/09
52.	Original article	Acute vascular rejection after renal transplantation and isolated v-lesion 2012/07
53.	Original article	Clinical and pathological analysis of transplant glomerulopathy cases 2012/07
54.	Original article	Immunohistological study of a pediatric patient with plasma cell-rich acute rejection 2012/07
55.	Original article	Improvement of Urinary Dysfunction After Kidney Transplantation by Administration of the Antimuscarinic Agent-Prospective Randomized Controlled Study 2012/03
56.	Original article	Clinicopathologic Analysis of Acute Vascular Rejection Cases After Renal Transplantation 2012/02
57.	Original article	The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience 2011/11
58.	Original article	Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy 2011/02
59.	Original article	BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report 2011
60.	Original article	Mild rhabdomyolysis after renal transplantation 2011
61.	Original article	Bladder function of end-stage renal disease patients 2010/09
62.	Original article	Clinicopathological analysis of acute vascular rejection cases after renal transplantation. 2010/07
63.	Original article	Changes in anti-HLA antibody titers more than 1 year after desensitization therapy with rituximab in living-donor kidney transplantation. 2010
64.	Original article	Evaluation of Low-Dose Rituximab Induction Therapy in Living Related Kidney Transplantation. 2010
65.	Original article	New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. 2010
66.	Original article	Retroperitoneoscopic living donor nephrectomy: experience of 425 cases at a single center. 2010
67.	Original article	Risk factors for deterioration of renal function after donor nephrectomy 2010
68.	Original article	Clinicopathological analysis of transplant glomerulopathy cases 2009/08
69.	Original article	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation:Long-term impact and risk factors 2009
70.	Original article	Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation 2009
71.	Original article	A case of plasma cell-rich acute rejection 18 months after kidney transplantation successfully treated with steroid pulse therapy 2008/07
72.	Original article	Persistent subclinical rejection associated with nodular B-cell infiltrates in a renal transplant recipient 2008/07
73.	Original article	Continent Orthotopic Ileal Neobladder After Kidney Transplantation in a Patient With Urothelial Cell Carcinoma Associated With Chinese Herb Nephropathy 2008/06
74.	Original article	Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation 2008/06
75.	Original article	Analysis of Renal Transplant Protocol Biopsies in ABO-Incompatible Kidney Transplantation 2008/01
76.	Original article	Clinical and Histological Analysis of Chronic Tacrolimus Nephrotoxicity in Renal Allografts 2008
77.	Original article	Evaluation of Immunosuppressive Regimens in ABO-Incompatible Living Kidney Transplantation-Single Center Analysis 2007/04
Display 5 items
Display all(77)

■ Academic conference presentation

1.	Assessing long-term complications of kidney transplantation without intraoperative ureteral dj stent: A single-center experience. 2023/06/06
2.	Elderly living kidney transplant donors and their renal prognosis. 2023/06/06
3.	Safety and efficacy of hypoxia-inducible factor prolyl hydroxylase inhibitor in kidney transplant patients with post-transplant anemia. 2023/06/05
4.	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. 2023/06/03
5.	Computational analysis of multiplex immunofluorescence imaging identifies endothelial cell-macrophage interaction as a potential novel spatial biomarker in antibody mediated kidney rejection. 2023/06/03
6.	10-years long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation. 2023/04/20
7.	CODEX multiplex immune-staining Identifies novel spatial indexes for antibody-mediated rejection diagnosis. 2023/04/20
8.	A case of living kidney transplantation suspected of hyper-acute rejection during kidney transplant surgery. 2022/11/26
9.	Clinicopathological analyses of chronic vascular rejection after kidney transplantation. 2022/11/26
10.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. 2022/11/26
11.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. 2022/10/24
12.	Desensitization protocol to prevent severe oliguric antibody-mediated rejection. 2022/06/05
13.	The relevance of naturally occurring non-HLA antibody to antibody-mediated rejection in patients without anti-HLA antibodies. 2021/08/29
14.	Relationship between tacrolimus blood levels and covid-19 pandemic in kidney transplant recipients. 2021/06/04
15.	Diagnosis and treatment for urolithiasis after kidney transplantation 2020/12/24
16.	Pathological investigation about renal transplant lost allografts. 2020/12/23
17.	Investigation of robotic assisted radical prostatectomy in our hospital. 2020/12/22
18.	Quantitative analysis of humoral immunity by flow-cytometric crossmatch using molecules of equivalent soluble fluorochromosome (FCXM-MESF). 2020/05/30
19.	Clinical and pathological analysis of chronic vascular rejection after kidney transplantation. 2019/09/24
20.	Correlation between the HLA antibody screening test and the specificity identification test. 2019/09/15
21.	Pregnancy outcomes in kidney transplant recipients. 2019/06/03
22.	Return to work after sick leave in kidney transplant recipients: A 365day cohort of the Japan academic consortium of kidney transplantation (JACK) study. 2019/06/03
23.	Evaluation of Urine BK Virus-PCR Measurement as a Screening Tool for Kidney Transplant Recipients 2018/11/24
24.	The Evaluation of Urine BK Virus PCR Measurement for Kidney Transplantation Recipients 2018/10/05
25.	Clinical and pathological analysis of chronic vascular rejection after renal transplantation. 2018/07/21
26.	Influence of trough level in tacrolimus on the appearance rate of de novo donor specific antibody (dnDSA) under low dose-based tacrolimus protocol during 7 years follow-up after renal transplantation. 2018/06/04
27.	Recurrence of immunoglobulin a nephropathy in related donor kidney transplant recipients. 2018/06/03
28.	Monoclonal IgG Deposits on Tubular Basement Membrane in Renal Allograft: Is This Significant for Chronic Allograft Injury? 2017/11/04
29.	Once-daily versus twice-daily tacrolimus in living kidney transplantation: A Multicenter, parallel group, open-label, 5-year, randomized non-inferiority trial. 2017/05/02
30.	Renal transplantation to the extraperitoneal cavity in children weighing less than 15 kg can be performed safely. 2017/05/02
31.	A comparative study of patient and graft qualities between abo- compatible and- incompatible recipients more than ten years after kidney transplantation. 2017/05/01
32.	Outcome of living-donor kidney transplantation in cross-match-positive recipients at a single center. 2017/04/29
33.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: Evolution of outcomes and immunosuppressive management. 2016/10/29
34.	Post-transplant diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. 2016/08/23
35.	Clinical and pathological analyses of interstitial fibrosis and tubular atrophy (IF/TA) cases after kidney transplantation. 2016/08/20
36.	Comparison of the pharmacokinetics and pathology for low-dose once-daily and twice-daily tacrolimus following living kidney transplantation: Five-year results from a prospective trial. 2016/08/20
37.	Efficacy and feasibility of radiotherapy for localized prostate cancer in renal transplant recipients: a single-center experience. 2016/08/20
38.	Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation: Is prophylactic treatment necessary? 2016/08/20
39.	Preemptive kidney transplantation in Japanese patients: A propensity score-matched study. 2016/08/20
40.	Relationship between de novo donor-specific anti-HLA-DQ antibody and chronic antibody-mediated rejection in kidney transplant recipients. 2016/08/20
41.	Relationship between dialysis duration and prevalence of cardiovascular diseases in kidney transplantation recipients. 2016/08/20
42.	Clinicopathological analysis of acute vascular rejection cases after kidney transplantaion. 2016/07/16
43.	The cases of two recipients of kidneys from an identical deceased donor who had diabetic nephropathy. 2016/07/16
44.	Glomerular capillary C4d staining without evidence of rejection is associated with worse graft function in ABO-incompatible Kidney Transplantation. 2016/06/13
45.	Pharmakokinetics of prolonged-release formulation of tacrolimus:Comparison of AUC0-24 and concentration at 10 time points. 2016/06/13
46.	Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation - Is prophylactic treatment necessary? 2016/06/13
47.	Relationship between dialisys duration and prevalence of cardiovascular diseases in kidney transplantation recipients. 2016/06/13
48.	The significance of microvascular inflammation in antibody-mediated rejection in ABO-incompatible kidney transplantation. 2016/06/13
49.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: evolution of outcomes and immunosuppressive management. 2016/06/11
50.	Association between pretransplant body mass index and outcomes in patients undergoing living kidney transplantation: A consideration of gender differences. 2016/06/11
51.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation - Prospective trial of once-daily vs.twice-daily Tac - 5 years second report. 2016/06/11
52.	An Investigation of 13 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation 2015/11/07
53.	Efficacy and feasibility of intensity-modulated radiation therapy for prostate cancer in renal-transplant recipients. 2015/08/26
54.	Efficacy and feasibility of low-dose brachytherapy for prostate cancer in renal-transplant recipients. 2015/08/26
55.	Robot-assisted radical prostatectomy in renal transplant recipients: the first report in asian patient. 2015/08/26
56.	Incidence of hepatitis B virus reactivation in kidney transplant patients who received rituximab administration. 2015/05/05
57.	Long-term excellent results of ABO-incompatible kidney transplantations at multicenter Japanese case series. 2015/05/04
58.	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2015/05/03
59.	Outcome of kidney transplantation from obese living donors: Histological evaluation using zero-time biopsy specimens. 2015/05/03
60.	Outcome of kidney transplantation from older living donors: Histological evaluation using zero-time biopsy specimens. 2015/05/03
61.	Outcome of kidney transplantation using right versus three left renal arteries after retroperitoneoscopic donor nephrectomy:A single-center experience of 764 cases. 2015/05/03
62.	Intimal arteritis associated with subsequent graft dysfunction in ABO-incompatible kidney transplantation. 2015/05/02
63.	Efficacy of rituximab, an anti-CD20 antibody for preventing hemolysis due to passenger leucocyte syndrome (PLS). 2014/07/30
64.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation -prospective trial of once-daily vs. twice-daily tac -3 years second report. 2014/07/29
65.	Long-term (more than 20 years) outcome of ABO-incompatible living donor kidney transplantation: A single center experience. 2014/07/29
66.	Outcomes of pure retroperitoneoscopic live donor nephrectomy (RPLDN): single center experience of 764 cases. 2014/07/29
67.	Outcomes of retroperitoneoscopic live donor nephrectomy in patients with renal artery aneurysm. 2014/07/29
68.	Retroperitoneoscopic procurement of kidneys with multiple renal arteries does not affect graft survival and ureteral complications. 2014/07/29
69.	Risk factors of preterm delivery at less than 35 weeks in patients with kidney transplantation. 2014/07/29
70.	The correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression including rituximab. 2014/07/29
71.	Assessment of long-term outcomes after kidney retransplantation. 2014/07/28
72.	Late-onset neutropenia (LON) After low-dose rituximab treatment in living related kidney transplantation.-Single-center study- 2014/07/28
73.	Lower incidence rate of BK virus nephropathy, as detected by PCR screening, associated with lower doses of Tac/MMF at Tokyo Women's Medical University. 2014/07/28
74.	No necessity for prophylactic B-Cell-targeting treatment for postoperative high titers of anti-blood type antibodies after ABO-incompatible living related kidney transplantation. 2014/07/28
75.	Clinical and pathological analysis of transplant glomerulopathy cases. 2014/07/27
76.	Influences of the CD20 Ab rituximab on the renal transplant recipients and renal grafts 5 to 8 years after immunologically high-risk renal transplantation. 2014/07/27
77.	Long-term outcomes of living donor kidney transplantation in flow cytometry crossmatch-positive patients: A single-center experience. 2014/07/27
78.	Preliminary outcome of desensitization with super high dose IVIG, plasmapheresis, and rituximab for crossmatch-positive (highly sensitized) kidney transplant recipients. 2014/07/27
79.	RESUL OF TRANSURETHRAL URETEROLITHOTRIPSY(TUL) AND CLINICAL CHARACTERISTICS OF ACUTE PYELONEPHRITIS FOLLWING TUL 2013/10/25
80.	A case of recurrent FSGS diagnosed as underlying disease following deceased donor kidney transplantation and a review of recurrent FSGS cases after transplantation at our institution 2013/09/04
81.	Evaluation of the association between histological findings of arteriosclerosis in zero-time biopsy and tacrolimus-induced nephrotoxicity 2013/09/04
82.	Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment 2013/05/21
83.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for over 20 Years 2013/05/21
84.	Incidence of Malignancy after Kidney Transplantation in the New Era of Immunosuppression 2013/05/21
85.	Evaluation of Low-Dose Rituximab Treatment;the Incidence of Graft Rejection and Adverse Events in 313 Living Kidney Transplant Recipients 2013/05/20
86.	Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity 2013/05/19
87.	Development of De Novo Anti-HLA Antibodies after Treatment with/without Rituximab, a BCell-Depleting Treatment 2013/05/19
88.	Influence of Preoperative Anti-HLA Antibodies on Short-Term and Long-Term Graft Survival in Recipients With or Without Rituximab Treatment 2013/05/19
89.	Microvascular Inflammation as a Core Element of Diagnostic Criteria of Antibody-Mediated Rejection(ABMR): C4d Positivity Is Not Reliable Element in Diagnosis of ABMR 2013/05/19
90.	MFI Detected by Luminex in Patients with Chronic Active Antibody Mediated Rejection 2012/10/20
91.	Outcomes of Retroperitoneoscopic Procurement of Kidneys with Multiple Renal Arteries 2012/10/20
92.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases 2012/07/19
93.	Clinicopathological Analysis of Acute Vascular Rejection Cases after Renal Transplantation 2012/07/19
94.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for Over 20 Years 2012/07/19
95.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome(FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation 2012/07/19
96.	Can We Predict the Occurrence of Medullary Ray Injury from the Investigation of Bladder Function before Kidney Transplantation? 2012/06/05
97.	The Signifi cance of Low Level DSA Detected by Solid Phase Assay in Association with Acute and Chronic Antibody Mediated Rejection 2012/06/05
98.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases 2012/06/04
99.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome (FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation 2012/06/04
100.	The Impact of B-Cell Depleting Treatment on Marked Reduction of Chronic Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation 2012/06/04
101.	An Open Label, Prospecive Randomized Controlled Study Comparing Tacrolimus Once-Daily and Twice-Daily in De Novo Kidney Transplatation: Pharmacokinetics and Pathological Analysis by Protocol Biopsy 2012/06/03
102.	Long-Term Follow-Up of Kidney Transplant Recipient with Calcineurin Inhibitor-Associated Nephrotoxicity 2012/06/03
103.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years 2012/06/02
104.	Impact of Right-sided Nephrectomy on Long-term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy 2012/04/23
105.	Prophylactic therapy for antibody-mediated rejection during introductory period in kidney transplantation(Symposium7 Antibody-mediated rejection in kidney transplantation) 2012/02/03
106.	Chimerism of blood type antigens on the vessel endothelium in patients with antibody-mediated rejection 2011/09/04
107.	Clinicopathological analysis of acute vascular rejection cases after renal transplantation 2011/06
108.	Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation 2011/06
109.	Impact and Implication of Renal Artery Number on Outcomes of Renal Donors and Recipients in Retroperitoneoscopic Live Donor Nephrectomy-Experience of 500 Cases at a Single Center 2011/05/03
110.	Impact of Right Nephrectomy on Long-Term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy:Experience of 479 Cases at a Single Center 2011/05/03
111.	Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 500 Cases at a Single Center 2011/05/03
112.	Excellent Outcomes of Rituximab Administration Plus Plasmapheresis as Prophylactic Treatment Prior to Kidney Transplantation in Patients with Focal Segmental Glomerulosclerosis 2011/05/02
113.	Decrease of Blood-Type Antigenicity over the Long-Term after ABO-Incompatible Kidney Transplantation 2011/05/01
114.	Significance of Qualitative and Quantitative Evaluations of Anti-HLA Antibodies in Kidney Transplantation 2011/05/01
115.	Significant Reduction in Chronic Antibody-Mediated Rejection after B-Cell Depleting Treatment in ABO-Incompatible Living Kidney Transplantation 2011/05/01
116.	Rituximab Therapy Reduces Peripheral B Cells for a Long Time in ABO Incompatible Kidney Transplantation; a Single Center Experience 2011/04/30
117.	Clinicopathological analysis of acute vascular rejection cases after renal transplantation 2010/05
118.	Excellent long-term outcomes of donor-specific anti-HLA antibody(DSA) positive renal transplant recipients and significant elimination of posttransplant DSA by combination treatment of basiliximab and rituxaimab inductoin 2010/05
119.	New-onset diabetes after transplantaion in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT 2010/05
120.	Outcome of kidney transplantation from living older donors: histologiucal evaluation using zero-time biopsy 2010/05
121.	Outcome of retroperitoneoscopic living donor nephrectomy in obese donors 2010/05
122.	Surgical complications of pediatric kidney transplantation:A single center experience 2010/05
123.	The Low dose rituximab preconditioning in ABO-incompatible kidney transplantation: A 3-year follow up 2010/05
Display 5 items
Display all(123)

■ Social activities

2017/03

1st East Asia Transplant Expert Meeting Discussion Banff classification Moderator

■ Research grants & projects

2022/04～2025/03

Assessing the risk of renal allograft' rejection by immunocytospatial analysis (Key Word : )

■ Education

1986/04～1992/03

Department of medicine, Faculty of Medicine, Shimane Medical University, Graduated, Medical doctor

■ Rsearch funding number

60307593